<DOC>
	<DOCNO>NCT03061825</DOCNO>
	<brief_summary>The purpose study evaluate clinical performance Zenith Alpha™ Abdominal Endovascular Graft treatment abdominal aortic aorto-iliac aneurysm .</brief_summary>
	<brief_title>Zenith Alpha™ Abdominal Endovascular Graft</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Iliac Aneurysm</mesh_term>
	<criteria>A patient consider eligible inclusion study patient infrarenal abdominal aortic aortoiliac aneurysm intend treat Zenith Alpha™ Abdominal Endovascular Graft Life expectancy le ( &lt; ) 2 year Inability refusal give informed consent patient legally authorize representative Unwilling unable comply study followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Aneurysm</keyword>
	<keyword>Aortic Aneurysm</keyword>
	<keyword>Aortic Aneurysm , Abdominal</keyword>
	<keyword>Iliac Aneurysm</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Aortic Diseases</keyword>
</DOC>